BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1777414)

  • 1. Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck.
    Yin XY; Donovan-Peluso M; Whiteside TL; Johnson JT; Day R; Herberman RB; Locker J
    Genes Chromosomes Cancer; 1991 Nov; 3(6):443-54. PubMed ID: 1777414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD; Cartwright SL; Schechter GL
    Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
    Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
    Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas.
    Lese CM; Rossie KM; Appel BN; Reddy JK; Johnson JT; Myers EN; Gollin SM
    Genes Chromosomes Cancer; 1995 Apr; 12(4):288-95. PubMed ID: 7539284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations for fine mapping of amplifications in chromosome 3q26.3-28 frequently occurring in squamous cell carcinomas of the head and neck.
    Riazimand SH; Welkoborsky HJ; Bernauer HS; Jacob R; Mann WJ
    Oncology; 2002; 63(4):385-92. PubMed ID: 12417794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of the head and neck.
    Yin XY; Smith ML; Whiteside TL; Johnson JT; Herberman RB; Locker J
    Int J Cancer; 1993 May; 54(2):322-7. PubMed ID: 8098018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
    Leonard JH; Kearsley JH; Chenevix-Trench G; Hayward NK
    Int J Cancer; 1991 Jun; 48(4):511-5. PubMed ID: 2045198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oncogenes in squamous epithelial cancers in the area of the head and neck].
    Volling P; Jungehülsing M; Tesch H; Stennert E
    Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
    Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
    Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.
    Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC
    Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
    Berenson JR; Yang J; Mickel RA
    Oncogene; 1989 Sep; 4(9):1111-6. PubMed ID: 2476705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent novel DNA copy number increase in squamous cell head and neck tumors.
    Brzoska PM; Levin NA; Fu KK; Kaplan MJ; Singer MI; Gray JW; Christman MF
    Cancer Res; 1995 Jul; 55(14):3055-9. PubMed ID: 7606727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
    Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
    Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression.
    Huang Q; Yu GP; McCormick SA; Mo J; Datta B; Mahimkar M; Lazarus P; Schäffer AA; Desper R; Schantz SP
    Genes Chromosomes Cancer; 2002 Jun; 34(2):224-33. PubMed ID: 11979556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization.
    Roman E; Meza-Zepeda LA; Kresse SH; Myklebost O; Vasstrand EN; Ibrahim SO
    Oncol Rep; 2008 Oct; 20(4):825-43. PubMed ID: 18813824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.
    Singh B; Gogineni SK; Sacks PG; Shaha AR; Shah JP; Stoffel A; Rao PH
    Cancer Res; 2001 Jun; 61(11):4506-13. PubMed ID: 11389082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
    Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of the timing of gene amplification during multistep head and neck tumorigenesis.
    Roh HJ; Shin DM; Lee JS; Ro JY; Tainsky MA; Hong WK; Hittelman WN
    Cancer Res; 2000 Nov; 60(22):6496-502. PubMed ID: 11103819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.